» Articles » PMID: 1804007

Attenuation of Antibody Response to Acute Pyelonephritis by Treatment with Antibiotics

Overview
Specialty Pharmacology
Date 1991 Nov 11
PMID 1804007
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

While acute pyelonephritis is known to elicit an antibody response, it is also known that a patient who has had pyelonephritis once is susceptible to recurrent renal infection. Using our experimental model of pyelonephritis in the monkey, we tested whether antibiotic therapy of the acute disease would affect the antibody response. We found that it did, because antibiotic therapy beginning 72 h after bacterial inoculation attenuated the antibody response so that rechallenge 3 months later produced acute pyelonephritis and prolonged bacteriuria. The animals with untreated infection had an antibody response that lasted a sufficient period of time to prevent acute pyelonephritis after renal challenge. We have confirmed that antibody titers against P fimbriae are protective, and to a degree, this protective effect may be abrogated by antibiotic therapy.

Citing Articles

Immunomodulating effects of antibiotics: literature review.

Van Vlem B, Vanholder R, De Paepe P, Vogelaers D, Ringoir S Infection. 1996; 24(4):275-91.

PMID: 8875279 DOI: 10.1007/BF01743360.

References
1.
Winberg J, Andersen H, Hanson L, Lincoln K . STUDIES OF URINARY TRACT INFECTIONS IN INFANCY AND CHILDHOOD. I. ANTIBODY RESPONSE IN DIFFERENT TYPES OF URINARY TRACT INFECTIONS CAUSED BY COLIFORM BACTERIA. Br Med J. 1963; 2(5356):524-7. PMC: 1872629. DOI: 10.1136/bmj.2.5356.524. View

2.
Roberts J, DOMINGUE G . Experimental pyelonephritis in the monkey. II. The prognostic value of radionuclide evaluation of the urinary tract. Invest Urol. 1975; 12(5):374-80. View

3.
Macleod C . Relation of the incubation period and the secondary immune response to lasting immunity to infectious diseases. J Immunol. 1953; 70(4):421-5. View

4.
Salit I, Hanley J, Clubb L, Fanning S . The human antibody response to uropathogenic Escherichia coli: a review. Can J Microbiol. 1988; 34(3):312-8. DOI: 10.1139/m88-057. View

5.
Roberts J, Kaack M, Baskin G, Korhonen T, Svenson S, Winberg J . P-fimbriae vaccines. II. Cross reactive protection against pyelonephritis. Pediatr Nephrol. 1989; 3(4):391-6. DOI: 10.1007/BF00850213. View